Dyno Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Dyno Therapeutics's estimated annual revenue is currently $28.9M per year.
- Dyno Therapeutics's estimated revenue per employee is $193,750
- Dyno Therapeutics's total funding is $109M.
Employee Data
- Dyno Therapeutics has 149 Employees.
- Dyno Therapeutics grew their employee count by 3% last year.
Dyno Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Co-founder & Executive Chairman | Reveal Email/Phone |
3 | Head Biology | Reveal Email/Phone |
4 | VP, Head Corporate Development | Reveal Email/Phone |
5 | Controller | Reveal Email/Phone |
6 | Head Platform | Reveal Email/Phone |
7 | Head Engineering | Reveal Email/Phone |
8 | Head Partner Success | Reveal Email/Phone |
9 | Director | Reveal Email/Phone |
10 | Sr. Director, Head Computation, ML Research Lead | Reveal Email/Phone |
Dyno Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Dyno Therapeutics?
Dyno Therapeutics is a Cambridge based, VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies.
keywords:N/A
$109M
Total Funding
149
Number of Employees
$28.9M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Dyno Therapeutics News
Gene therapy companies have been especially vulnerable to a public market ... Stride Bio, Affinia Therapeutics and Dyno Therapeutics,...
The gene therapy vectors were developed leveraging Dyno's CapsidMap platform, which utilises artificial intelligence to quickly optimise AAV...
Astellas' gene therapy programmes largely stemming from its $3 ... by Dyno Therapeutics, designed to improve the safety of the vectors.
Dyno Therapeutics, a biotech startup that's applying AI to gene therapy, has announced a $100 million Series A led by Andreessen Horowitz, with participation from new investors including Casdin Capital, GV, Obvious Ventures and Lux Capital. Existing backers Polaris Partners, CRV and KdT also par ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.6M | 149 | 2% | N/A |
#2 | $23.1M | 149 | 6% | N/A |
#3 | $15M | 149 | -10% | N/A |
#4 | $36.1M | 149 | 5% | N/A |
#5 | $3.5M | 150 | 7% | N/A |